Recent Publications

Recent Publications

2017 | 2016 | 2015 | 2014 | 2013

2014

Dec 08, 2014
Ito, M., Hayashi, K., Adachi, E., Minamisawa, T., Homma, S., Koido, S., Shiba, K.
Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity.
PLoS One, 9, e110425 (2014)
Dec 05, 2014
Isoyama, S., Kajiwara, G., Tamaki, N., Okamura, M., Yoshimi, H., Nakamura, N., Kawamura, K., Nishimura, Y., Namatame, N., Yamori, T., Dan, S.
Basal expression of IGF-1 receptor determines intrinsic resistance of cancer cells to a PI3K inhibitor ZSTK474.
Cancer Sci, 106, 171-178 (2015)
Nov 21, 2014
Uehara, Y., Inoue, M., Fukuda, K., Yamakoshi, H., Hosoi, Y., Kanda, H., Oshima, M., Iwabuchi, Y., Shibata, H.
Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo.
Gastric cancer, in press (2014)
Nov 21, 2014
Sekiguchi, K., Ogawa, Y., Sanuki, N., Arahira, S., Ogo, E., Yoshimura, M., Yamauchi, C., Oguchi, M., Ohsumi, S., Mukai, H.
The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer.
Breast Cancer, in press (2014)
Nov 21, 2014
Honma, N., Horii, R., Iwase, T., Saji, S., Younes, M., Ito, Y., Akiyama, F.
Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy.
Breast, in press (2014)
Nov 21, 2014
Yamaguchi, J., Nagayama, S., Chino, A., Sakata, A., Yamamoto, N., Sato, Y., Ashihara, Y., Kita, M., Nomura, S., Ishikawa, Y., Igarashi, M., Ueno, M., Arai, M.
Identification of coding exon 3 duplication in the BMPR1A gene in a patient with juvenile polyposis syndrome.
Jpn J Clin Oncol, in press (2014)
Nov 21, 2014
Horii, R., Matsuura, M., Dan, S., Ushijima, M., Uehiro, N., Ogiya, A., Honma, N., Ito, Y., Iwase, T., Yamori, T., Akiyama, F.
Extensive analysis of signaling pathway molecules in breast cancer: association with clinicoapthological characteristics.
Int J Clin Oncol, in press (2014)
Nov 21, 2014
Nakagawa, T., Horii, R., Ito, Y., Iwase, T., Akiyama, F.
Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization.
Breast Cancer, in press (2014)
Nov 21, 2014
Katayama, R., Friboulet, L., Koike, S., Lockerman, E.L., Khan, T.M., Gainor, J.F., Iafrate, A.J., Takeuchi, K., Taiji, M., Okuno, Y., Fujita, N., Engelman, J.A., Shaw, A.T.
Two novel ALK mutations mediate acquired resistance to the next-generation AKL inhibitor alectinib.
Clin Cancer Res, in press (2014)
Nov 21, 2014
Kim, S.J., Masuda, N., Tsukamoto, F., Inaji, H., Akiyama, F., Sonoo, H., Kurebayashi, J., Yoshidome, K., Tsujimoto, M., Takei, H., Masuda, S., Nakamura, S., Noguchi, S.
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy.
Cancer Lett, 355, 217-223 (2014)
Nov 21, 2014
Rempel, R.E., Jiang, X., Fullerton, P., Tan, T.Z., Ye, J., Lau, J.A., Mori, S., Chi, J.T., Nevins, J.R., Friedman, D.R.
Utilization of the Eμ-Myc mouse to model heterogeneity of therapeutic response.
Mol Cancer Ther, 13, 3219-3229 (2014)
Nov 21, 2014
Miow, Q.H., Tan, T.Z., Ye, J., Lau, J.A., Yokomizo, T., Thiery, J.P., Mori, S.
Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer.
Oncogene, 34, 1899-1907 (2014)
Nov 21, 2014
Nakano, K., Inagaki, L., Tomomatsu, J., Motoi, N., Gokita, T., Ae, K., Tanizawa, T., Shimoji, T., Matsumoto, S., Takahashi, S.
Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
Clin Oncol, 26, 357 (2014)
Nov 21, 2014
Gorai, A., Sakao, Y., Kuroda, H., Uehara, H., Mun, M., Ishikawa, Y., Nakagawa, K., Masuda, M., Okumura, S.
The clinicopathological features associated with skip N2 metastases in patients with clinical stage IA non-small-cell lung cancer.
Eur J Cardiothorac Surg, 47, 653-658 (2015)
Nov 21, 2014
Horii, R., Honma, N., Ogiya, A., Kozuka, Y., Fukuda, T., Yoshida, M., Ohsumi, S., Mukai, H.
The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer.
Breast Cancer, 22, 59-65 (2015)
Oct 30, 2014
Katayama, R., Kobayashi, Y., Friboulet, L., Lockerman, E.L., Koike, S., Shaw, A.T., Engelman, J.A., Fujita, N.
Cabozantinib overcomes crizotinib resistance in ROS1 fusion positive cancer.
Clin Cancer Res, in press (2014)
Oct 29, 2014
Kodama, T., Motoi, N., Ninomiya, H., Sakamoto, H., Kitada, K., Tsukaguchi, T., Satoh, Y., Nomura, K., Nagano, H., Ishii, N., Terui, Y., Hatake, K., Ishikawa, Y.
A novel mechanism of EML4-ALK rearrangement mediated by chromothripsis in a patient-derived cell Ll.
J Thorac Oncol, in press (2014)
Oct 29, 2014
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H.
Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma.
Hematol Oncol, in press (2014)
Oct 29, 2014
Nakada, T., Okumura, S., Kuroda, H., Uehara, H., Mun, M., Takeuchi, K., Nakagawa, K.
Imaging characteristics in ALK fusion-positive lung adenocarcinomas by using HRCT.
Ann Thorac Cardiovasc Surg, in press (2014)
Oct 29, 2014
Nitta, H., Terui, Y., Yokoyama, M., Mishima, Y., Nishimura, N., Ueda, K., Kusano, Y., Tsuyama, N., Takeuchi, K., Kanda, Y., Hatake, K.
Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma.
Haematologica, in press (2014)
Oct 29, 2014
Sakurai, H., Sugimoto, K.J., Shimada, A., Imai, H., Wakabayashi, M., Sekiguchi, Y., Ota, Y., Izutsu, K., Takeuchi, K., Komatsu, N., Noguchi, M.
Primary CNS CCND1/MYC-positive double-hit B-cell lymphoma: A case report and review of the literature.
J Clin Oncol, in press (2014)
Oct 29, 2014
Tomita, N., Kodama, F., Tsuyama, N., Sakata, S., Takeuchi, K., Ishibashi, D., Koyama, S., Ishii, Y., Yamamoto, W., Takasaki, H., Hagihara, M., Kuwabara, H., Tanaka, M., Hashimoto, C., Yamazaki, E., Koharazawa, H., Fujimaki, K., Sakai, R., Fujisawa, S., Ishigatsubo, Y.
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Hematol Oncol, in press (2014)
Oct 29, 2014
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R.
HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study.
Leuk Lymphoma, in press (2014)
Oct 14, 2014
Aoyama, A., Katayama, R., Oh-hara, T., Sato, S., Okuno, Y., Fujita, N.
Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance.
Mol Cancer Ther, in press (2014)

Oct 07, 2014
Alewine, C., Xiang, L., Yamori, T., Niederfellner, G., Bosslet, K., Pastan, I.
Efficacy of RG7787, a Next Generation Mesothelin-targeted Immunotoxin, Against Triple-negative Breast and Gastric Cancers.
Mol Cancer Ther, in press (2014)
Oct 07, 2014
Horii, R., Matsuura, M., Dan, S., Ushijima, M., Uehiro, N., Ogiya, A., Honma, N., Ito, Y., Iwase, T., Yamori, T., Akiyama, F.
Extensive analysis of signaling pathway molecules in breast cancer: association with clinicoapthological characteristics.
Int J Clin Oncol, in press (2014)
Oct 07, 2014
Kong, D., Yamori, T., Yamazaki, K., Dan, S.
In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA.
Invest New Drugs, in press (2014)
Oct 07, 2014
Momose, I., Abe, H., Watanabe, T., Ohba, S.I., Yamazaki, K., Dan, S., Yamori, T., Masuda, T., Nomoto, A.
Antitumor effects of tyropeptin-boronic acid derivatives: new proteasome inhibitors.
Cancer Sci, in press (2014)
Sep 18, 2014
Katayama, R., Friboulet, L., Koike, S., Lockerman, E.L., Khan, T.M., Gainor, J.F., Iafrate, A.J., Takeuchi, K., Taiji, M., Okuno, Y., Fujita, N., Engelman, J.A., Shaw, A.T.
Two novel ALK mutations mediate acquired resistance to the next-generation AKL inhibitor alectinib.
Clin Cancer Res, in press (2014)
Aug 21, 2014
Miyata, K., Takagi, S., Sato, S., Morioka, H., Shiba, K., Minamisawa, T., Takami, M., Fujita, N.
Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment.
Cancer Med, in press (2014)
Jun 26, 2014
Mashima, T., Soma-Nagase, T., Migita, T., Kinoshita, R., Iwamoto, A., Yuasa, T., Yonese, J., Ishikawa, Y., Seimiya, H.
TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression.
Cancer Res., in press (2014)
May 07, 2014
Nakamura, S., Takahashi, M., Tozaki, M., Nakayama, T., Nomizu, T., Miki, Y., Murakami, Y., Aoki, D., Iwase, T., Nishimura, S., Yamauchi, H., Ohsumi, S., Baba, S., Shimizu, T.
Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.
Breast Cancer, in press (2013)
May 07, 2014
Ogura, K., Horii, R., Oosako, T., Iwase, T., Akiyama, F.
A clinico-pathological study on cancer in sclerosing adenosis.
Breast Cancer, in press (2013)
May 07, 2014
Horii, R., Akiyama, F.
Histological assessment of therapeutic response in breast cancer.
Breast Cancer, in press (2013)
May 07, 2014
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R.
HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study.
Leuk Lymphoma, in press (2014)
May 07, 2014
Tomita, N., Kodama, F., Tsuyama, N., Sakata, S., Takeuchi, K., Ishibashi, D., Koyama, S., Ishii, Y., Yamamoto, W., Takasaki, H., Hagihara, M., Kuwabara, H., Tanaka, M., Hashimoto, C., Yamazaki, E., Koharazawa, H., Fujimaki, K., Sakai, R., Fujisawa, S., Ishigatsubo, Y.
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Hematol Oncol, in press (2014)
May 07, 2014
Osako, T., Iwase, T., Ushijima, M., Horii, R., Fukami, Y., Kimura, K., Matsuura, M., Akiyama, F.
Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.
Cancer Sci, in press (2014)
May 07, 2014
Nakano, K., Inagaki, L., Tomomatsu, J., Motoi, N., Gokita, T., Ae, K., Tanizawa, T., Shimoji, T., Matsumoto, S., Takahashi, S.
Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.
Clin Oncol, in press (2014)
May 07, 2014
Nakagawa, T., Horii, R., Ito, Y., Iwase, T., Akiyama, F.
Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization.
Breast Cancer, in press (2014)
May 07, 2014
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H.
Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma.
Hematol Oncol, in press (2014)
May 07, 2014
Kenmotsu, H., Niho, S., Ito, T., Ishikawa, Y., Noguchi, M., Tada, H., Sekine, I., Watanabe, S.I., Yoshimura, M., Yamamoto, N., Oshita, F., Kubota, K., Nagai, K.
A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
Lung Cancer, in press (2014)
May 07, 2014
Kadota, K., Villena-Vargas, J., Yoshizawa, A., Motoi, N., Sima, C.S., Riely, G.J., Rusch, V.W., Adusumilli, P.S., Travis, W.D.
Prognostic significance of adenocarcinoma In situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Am J Surg Pathol, in press (2014)
May 07, 2014
Jin, M., Zhou, Q., Lee, E., Dan, S., Duan, H.Q., Kong, D.
AS252424, a PI3Kγ inhibitor, down-regulates inflammatory responsiveness in mouse bone marrow-derived mast cells.
Inflammation, in press (2014)
Apr 23, 2014
Ohishi, T., Muramatsu, Y., Yoshida, H., Seimiya, H.
TRF1 ensures the centromeric function of Aurora-B and proper chromosome segregation.
Mol Cell Biol, in press (2014)
Apr 18, 2014
Matsumura, S., Yuge, R., Sato, S., Tomida, A., Ichihashi, T., Irie, H., Iijima, S., Shiba, K., Yudasaka, M.
Ultrastructural localization of intravenously injected carbon nanohorns in tumor.
Int J Nanomedicine, in press (2014)
Apr 11, 2014
Sakurai, H., Sugimoto, K.J., Shimada, A., Imai, H., Wakabayashi, M., Sekiguchi, Y., Ota, Y., Izutsu, K., Takeuchi, K., Komatsu, N., Noguchi, M.
Primary CNS CCND1/MYC-Positive Double-Hit B-Cell Lymphoma: A Case Report and Review of the Literature.
J Clin Oncol, in press (2014)
Mar 28, 2014
Friboulet, L., Li, N., Katayama, R., Lee, C.C., Gainor, J.F., Crystal, A.S., Michellys, P.Y., Awad, M.M., Yanagiani, N., Kim, S., Pferdekamper, A.C., Li, J., Kasibhatla, S., Sun, F., Sun, X., Hua, S., McNamara, P., Mahmood, S., Lockerman, E.L., Fujita, N., Nishio, M., Harris, J.L., Shaw, A.T., Engelman, J.A.
The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer.
Cancer Discov, in press (2014)
Feb 27, 2014
Horii, R., Akiyama, F.
Histological assessment of therapeutic response in breast cancer.
Breast Cancer, in press (2013)
Feb 27, 2014
Ogura, K., Horii, R., Oosako, T., Iwase, T., Akiyama, F.
A clinico-pathological study on cancer in sclerosing adenosis.
Breast Cancer, in press (2013)
Feb 27, 2014
Ono, H., Motoi, N., Nagano, H., Miyauchi, E., Ushijima, M., Matsuura, M., Okumura, S., Nishio, M., Hirose, T., Inase, N., Ishikawa, Y.
Long non-coding RNA HOTAIR is relevant to cellular proliferation, invasiveness and clinical relapse in small cell lung cancer.
Cancer Med, in press (2013)
Feb 25, 2014
Lee, S.E., Kang, S.Y., Takeuchi, K., Ko, Y.H.
Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma.
Hematol Oncol, in press (2014)
Feb 25, 2014
Tomita, N., Kodama, F., Tsuyama, N., Sakata, S., Takeuchi, K., Ishibashi, D., Koyama, S., Ishii, Y., Yamamoto, W., Takasaki, H., Hagihara, M., Kuwabara, H., Tanaka, M., Hashimoto, C., Yamazaki, E., Koharazawa, H., Fujimaki, K., Sakai, R., Fujisawa, S., Ishigatsubo, Y.
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Hematol Oncol, in press (2014)
Feb 25, 2014
Yamamoto, W., Nakamura, N., Tomita, N., Takeuchi, K., Ishii, Y., Takahashi, H., Watanabe, R., Takasaki, H., Motomura, S., Kobayashi, S., Yokose, T., Ishigatsubo, Y., Sakai, R.
HLA-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B cell lymphoma treated by R-CHOP therapy: Retrospective cohort study.
Leuk Lymphoma, in press (2014)

Return to Top of Page